TrialThe Journal of rheumatology2019

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

Elizabeth R Volkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.